Related by context. Frequent words. (Click for all words.) 61 Phase IIa trial 61 Phase 2a trial 60 Phase III trials 60 clinical trial 59 Phase IIb trial 59 daclizumab 59 mipomersen 59 Phase 2b study 58 phase IIb 58 Phase 2b trial 57 ustekinumab 57 picoplatin 56 T DM1 56 Orexigen Therapeutics Inc. 56 Sprycel 56 Phase IIa clinical 56 TroVax 56 Phase IIb 56 Qnexa 55 Phase 2a clinical 55 Phase III clinical 55 Antegren 55 Phase IIb clinical 55 telaprevir 55 Bydureon 54 INCB# [002] 54 investigational compound 54 clinical trials 54 LymphoStat B 54 lorcaserin 54 bapineuzumab 54 Phase 2b clinical 54 sunitinib 54 AZD# 53 Phase Ib 53 Entereg 53 denufosol 53 Phase 2a 53 antisense drug 53 vandetanib 53 anacetrapib 53 blinatumomab 53 Contrave 53 Phase 1b 53 denosumab 53 primary endpoints 53 Trexima 53 preclinical 53 Phase IIa 52 ISIS # 52 Vectibix 52 primary endpoint 52 panitumumab 52 Lorcaserin 52 Revlimid 52 ASA# 52 Onyx Pharmaceuticals 52 preclinical studies 52 Phase III 52 CRx 52 Zerenex 52 TNFerade 52 Hematide 52 Phase III clinical trials 52 perifosine 52 elesclomol 52 avanafil 52 ARRY 51 alfimeprase 51 HspE7 51 pimavanserin 51 Cimzia 51 investigational drug 51 Bronchitol 51 Dimebon 51 Marqibo 51 FTY# 51 PRX # 51 non inferiority 51 ranibizumab 51 Denosumab 51 pivotal Phase III 51 Nexavar 51 dasatinib 51 Tykerb 50 telavancin 50 primary efficacy endpoint 50 LEVADEX 50 Velcade 50 Clolar 50 Yondelis 50 pirfenidone 50 PLX# 50 ALKS 50 chronic myeloid leukemia CML 50 ipilimumab 50 Mozobil 50 alemtuzumab 50 dapagliflozin 50 Orexigen 50 tolerability